1Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer, 2002, 2: 584-593.
2Roodman GD. Mechanisms of bone metastasis. N Engl J Med,2004, 350: 1655-1664.
3Rosen LS, Gordon DH, Dugan W Jr, et al.Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion. Cancer,2004, 100(1) : 36-43.
4Fidler IJ. The pathogenesis of cancer metastasis: the “seed andsoil” hypothesis revisited. Nat Rev Cancer, 2003, 3: 453-458.
5Wyatt CA, Geoghegan JC, Brinckerhoff CE. Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 coals:effects on matrix destruction and tumor growth. Cancer Res, 2005,65(23) : 11101-11108.
6Mastro AM, Gay CV, Welch DR. The skeleton as a unique environment for breast cancer cells. Clin Exp Metastasis, 2003, 20:275-284.
7Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410: 50-56.
8Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res,2004, 64(12) : 4302-4308.
9Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 2003, 3: 537-549.
10Takayama S, Ishii S, Ikeda T, et al. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Anticancer Res, 2005, 25(1A): 79-83.
8Hamaoka T,Madewell JE,Podoloff DA,et al.Bone imaging in metastatic breast cancer[J].J Clin Oncol,2004,22(14):2942-2953.
9Roodman GD.Mechanisms of bone metastasis[J].N Engl J Med,2004,350(16):1655-1664.
10Minn AJ,Kang Y,Serganova I,et al.Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors[J].J Clin Invest,2005,115(1):44-55.
